Administrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the ...
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
The admission of Ukraine into NATO could lead to World War III, the former Russian President Dmitry Medvedev has said Medvedev was Russia's head of state between 2008 and 2012 and now serves as ...
Prince Andrew’s privileged days are over. A new book from acclaimed royal biographer Robert Hardman, titled “Charles III: New King. New Court. The Inside Story,” claims that King Charles III ...
Jamie Dimon typically pays close attention to the workings of financial markets and the Federal Reserve, but today his most important concern is geopolitics. The economic outlook “is teeny ...
The Marshall Monitor III ANC headphones have so far honored the brand’s music heritage by putting on a great performance, boasting a rugged design that could seemingly survive the rowdiest mosh ...
The company—the U.S.’ top supplier of hospital IV fluids and peritoneal dialysis solutions—reduced its orders to hospitals and health systems after Hurricane Helene took down one of its ...
Oct. 31 (UPI) --A North Carolina facility is leading efforts to restore the nation's depleted supply of IV solutions after Hurricane Helene temporarily put it out of business. The shortage of IV ...
A quantitative flow ratio (QFR)-guided strategy did not provide the same prognostic benefits as a fractional flow reserve (FFR)-guided strategy for patients with intermediate coronary stenosis, based ...
Yeh, MD, FACC, et al. "…Our findings in TARGET-IV NA showed excellent clinical outcomes in both randomized groups, with primary outcome event rates lower than those reported in previous studies." ...
The surgery was off because there wasn't enough IV fluid to proceed. "I was having such a hard time processing what she was even saying to me, that I was just really quiet," she says, explaining ...
A Baxter spokesperson confirmed the decision to Fierce Pharma Wednesday, citing a fragmented local IV solutions market and the impact from Hurricane Helene on U.S. supplies. “The fragmented ...